{"url_path":"/sec/pmi/10-k/2026/item-11","section_key":"item-11","section_title":"Item 11 EXECUTIVE COMPENSATION**","topic":"sec","document":{"doc_type":"10-K/A","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001437749-26-017171-index.html","accession_number":"0001437749-26-017171","cik":"0002030617","ticker":"PMI","issuer_name":"Picard Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001437749-26-017171-index.html","primary_entity_key":"0002030617","primary_entity_name":"Picard Medical, Inc."},"word_count":163,"has_tables":true,"body_markdown":"**ITEM 11. EXECUTIVE COMPENSATION**\n\n \n\n**Director Compensation Program**\n\n \n\nDirectors who are officers of the Company do not receive compensation for their service as directors.\n\n \n\nWe provide the following compensation for non-management directors:\n\n \n\n●\n\nEach non-management director receives an annual director’s fee payable in cash equal to $35,000 and an annual grant of $15,000 stock options;\n\n \n\n●\n\nThe chair of the audit committee receives an additional annual fee payable in cash equal to $15,000; \n\n \n\n●\n\nThe chair of the compensation committee receives an additional annual fee payable in cash equal to $10,000.\n\n \n\nWe also reimburse directors for all expenses incurred in attending Board and committee meetings.\n\n \n\nThe following table provides information regarding the compensation of our non-management directors for the year ended December 31, 2025:\n\n \n\n**Name**\n\n \n\n**Fees Earned Or**\n\n**Paid in Cash**\n\n \n \n\n**Stock Option Awards**\n\n \n \n\n**Total**\n\n \n\nRichard Fang\n\n \n\n$\n\n-\n\n \n \n\n$\n\n-\n\n \n \n\n$\n\n-\n\n \n\nSam Van\n\n \n\n$\n\n16,667\n\n \n \n\n$\n\n-\n\n \n \n\n$\n\n16,667\n\n \n\nGeorge Ye\n\n \n\n$\n\n15,000\n\n \n \n\n$\n\n-\n\n \n \n\n$\n\n15,000\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nTable of Contents\n\n \n\n**PART IV**"}